Biovie Inc (BIVI)

02:42 AM

Press Release Distribution & PR Platform - ACCESS Newswire

02:42 AM

Apr 27, 2025

Bank of Montreal Can Invests $100,000 in BioVie Inc. (NASDAQ:BIVI) - Defense World

Apr 27, 2025

Apr 22, 2025

BioVie (NASDAQ:BIVI) Trading Down 5.6% – Should You Sell? - Defense World

Apr 22, 2025

Apr 20, 2025

Financial Contrast: BioVie (NASDAQ:BIVI) vs. DiaMedica Therapeutics (NASDAQ:DMAC) - Defense World

Apr 20, 2025

Apr 16, 2025

BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim In Early Parkinson's Disease - Nasdaq

Apr 16, 2025

Apr 16, 2025

BioVie (BIVI) Launches Phase 2 SUNRISE-PD Trial for Parkinson's Treatment | BIVI Stock News - GuruFocus

Apr 16, 2025

Apr 16, 2025

BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled - GlobeNewswire

Apr 16, 2025

Apr 16, 2025

Breakthrough Parkinson's Drug Enters Critical Phase 2 Trial: First Patient Dosed - Stock Titan

Apr 16, 2025

Apr 14, 2025

New to The Street's FOX Business "Late Night T.V." Special Airs Tonight – Show #650 – Featuring Health In Tech CEO Julia Qian (NASDAQ:HIT), BioVie's Dr. Joseph Palumbo (NASDAQ:BIVI), eXoZymes Co-Founder & VP of Research Tyler Korman (EXOZ), a - voiceofalexandria.com

Apr 14, 2025

Apr 12, 2025

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of BioVie Inc.(BIVI) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Apr 12, 2025

Apr 11, 2025

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BIOVie’s Dr. Joe Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice - Hastings Tribune

Apr 11, 2025

Apr 11, 2025

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BioVie's Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vic - voiceofalexandria.com

Apr 11, 2025

Apr 11, 2025

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vi - Newswire.com

Apr 11, 2025

Apr 08, 2025

Constellation Brands Q4 2025 Earnings Call Transcript - MarketBeat

Apr 08, 2025

Apr 08, 2025

ALERT: Grabar Law Office Investigates Claims on Behalf of - GlobeNewswire

Apr 08, 2025

Apr 07, 2025

ALERT: Grabar Law Office Investigates Claims on Behalf of Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); BioVie Inc. (NASDAQ: BIVI); Maison Solutions Inc. (NASDAQ: MSS); and Virtu Financial Inc. (NASDAQ: VIRT), as Securities Fraud Class - TradingView

Apr 07, 2025

Apr 05, 2025

UPCOMING BIVI DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds BioVie Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Apr 05, 2025

Apr 04, 2025

SHAREHOLDER ALERT: Levi & Korsinsky Reminds BioVie Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024BIVI - ACCESS Newswire

Apr 04, 2025

Apr 04, 2025

SECURITIES FRAUD CLASS ACTIONS SURVIVE MOTIONS TO DISMISS: - GlobeNewswire

Apr 04, 2025

Apr 04, 2025

SECURITIES FRAUD CLASS ACTIONS SURVIVE MOTIONS TO DISMISS: Grabar Law Office Investigates Claims on Behalf of Shareholders of Arqit Quantum Inc. (NASDAQ: ARQQ); Axsome Therapeutics, Inc. (NASDAQ: AXSM); BioVie Inc. (NASDAQ: BIVI); a - Morningstar

Apr 04, 2025

Apr 03, 2025

BioVie Inc. (BIVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Apr 03, 2025

Apr 03, 2025

BioVie (BIVI) Faces Securities Fraud Class Action After Uncovering Potential Scientific Misconduct In Failed Phase 3 Clinical Trial – Hagens Berman - ACCESS Newswire

Apr 03, 2025

Apr 02, 2025

BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire

Apr 02, 2025

Apr 02, 2025

Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire

Apr 02, 2025

Apr 02, 2025

BioVie Inc. (BIVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Apr 02, 2025

Apr 02, 2025

BioVie Inc. ($BIVI) Joins Forces With New to The Street for a Dynamic 6-Part Media Campaign Featuring Long-Form Interviews, National TV Commercials, Iconic Billboards, and Exclusive Accredited Events - ACCESS Newswire

Apr 02, 2025

Apr 01, 2025

Biovie stock hits 52-week low at $0.98 amid sharp annual decline - Investing.com Canada

Apr 01, 2025

Mar 31, 2025

Biovie stock hits 52-week low at $0.98 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

BioVie Investors Advance Lawsuit Over Alzheimer's Drug Trial - Bloomberg Law News

Mar 31, 2025

Mar 29, 2025

New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc. - ACCESS Newswire

Mar 29, 2025

Mar 28, 2025

BioVie announces board member resignation By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

BioVie announces board member resignation - Investing.com India

Mar 28, 2025

Mar 28, 2025

BioVie to Host KOL Investor Webcast to Discuss the Long - GlobeNewswire

Mar 28, 2025

Mar 27, 2025

BioVie to Host KOL Investor Webcast to Discuss the Long COVID Treatment Landscape and its ADDRESS-LC Trial on April 10, 2025 - The Manila Times

Mar 27, 2025

Mar 27, 2025

Yale KOL Reveals Latest Long COVID Breakthrough: BioVie's Novel Treatment Shows Promise - Stock Titan

Mar 27, 2025